The Core Facility Genomics (CFG) of Amsterdam UMC facilitates the use of cutting-edge technology through centralized investment, management and maintenance of genomics equipment.
Amsterdam UMC Biobank provides comprehensive services for the storage, logistics and data management of research collections of human specimens.
The Nobel prize winning CRISPR/Cas technology for rapid gene editing and DNA detection has an expanding impact on biomedical research and clinical practice
Gene silencing libraries and high-throughput liquid handling technology for functional genomic screening to understand the biology of disease and discover new therapeutic targets.
The Core Facility Metabolomics (CFM) is characterized by state-of-the-art mass spectrometry equipment, professional bioinformatics tools and expert knowledge in metabolism.
The Microscopy and Cytometry core facilities of the Amsterdam UMC offer a wide array of analytical posibilities for cell organeles, cells, and tissues.
The OncoProteomics Laboratory performs mass spectrometry-based proteomics strategies to improve our knowledge of disease, cellular signaling pathways, biomarkers, targets and drug effects.
RICC is the expertise center for multimodality in vivo imaging in clinical and pre-clinical cross-sectional and tracer research